Visible disability as a presenting feature of leprosy: a rare but real concern in post-elimination phase in India
Keywords:Leprosy, Impairment, Disability, Diagnostic delay
Leprosy (Hansen's disease) is a chronic infectious disease caused by Mycobacterium leprae, affecting mainly peripheral nerves and skin. Delayed diagnosis contributes to sensory-motor impairment leading to deformity and disability, thereby imposing a major impact on the physical, social, economic and psychological domains of the quality of life of affected individuals. Deformities and disabilities are largely preventable complications associated with tremendous social stigma and discrimination, assuming public health significance. India declared elimination of leprosy more than a decade and half ago in 2005. Hence, grade 2 disability is expected to be a rare manifestation in the post-elimination era. However, to the contrary, the proportion of new leprosy patients with visible disability recorded in India exceeds the global rate. Herein we report a middle-aged female presenting with saddle nose, bilateral fixed ulnar and mobile median claw hands (grade 2 disability) with multiple trophic ulcers. This case emphasizes that clinical suspicion after careful examination of skin and neural manifestations is of utmost importance for the early diagnosis of leprosy. Timely self-reporting and management with WHO-multi drug therapy (MDT) remains the key to minimize the risk of deformity and disability. Above all, it is essential to create awareness amongst the community regarding prompt recognition of symptoms and easy access to appropriate care along with intensified efforts to address the associated stigma.
World Health Organization. Weekly epidemio-logical record, 2020. Available at: https://www.who.int/wer/2020/wer9536/en/. . Accessed 10 January 2021.
Jain PK, Tripathi D, Singh CM, Srivastava DK, Sharma A, Bansal M. Study of high disability rate among leprosy affected persons in Gwalior District. Ind J Comm Health. 2011;23(2):90-2.
Ridley DS. Classification of leprosy - a window on leprosy. In: Evans AS, Feldman HA, eds. Springer Nature’s Bacterial Infections on Humans. 1st ed. Boston, MA: Springer; 1978: 112.
Kar HK, Gupta R. Treatment of leprosy. Clin Dermatol. 2015;33(1):55-65.
Miyashiro D, Cardona C, Valente NY, Avancini J, Benard G, Trindade MA. Ulcers in leprosy patients, an unrecognized clinical manifestation: a report of 8 cases. BMC Infect Dis. 2019;19(1):1013.
Venkatesan K, Neo D. Biochemical aspects of leprosy. In: Kumar B, Kar HK, eds. IAL Textbook of Leprosy. 2nd ed. New Delhi: Jaypee Brothers; 2016.
Srinivas G, Muthuvel T, Lal V, Vaikundanathan K, Schwienhorst-Stich EM, Kasang C. Risk of disability among adult leprosy cases and determinants of delay in diagnosis in five states of India: a case-control study. PLoS Neglected Tropical Diseases. 2019;13(6):7495.
Jindal N, Shanker V, Tegta GR, Gupta M, Verma GK. Clinicoepidemiological trends of leprosy in Himachal Pradesh: a five year study. Indian J Lepr. 2009;81(4):173-9.
Withington SG . Leprosy and disability in Bangladesh. Asia Pacific Disab Rehab J. 2005;22:88.
Kumar A, Chakma JK, Yadav VS, Girdhar A, Girdhar BK. Leprosy scenario in Agra: epidemiological observations from rapid population survey 2004- 06. J Commun Dis. 2008;40(4):277-84.